Transcript Perry Zinn Rowthorn Presentation

NAAG Presidential Initiative
Attorney General
George Jepsen
Challenges in Health Care
Cost, Competition and Policy
Innovation
Goals:
• To help Attorneys General “unpack” complex
challenges in health care marketplace.
• To generate broad, bipartisan discussion
among key players on healthcare policy.
Focus:
• Keynote speeches and panel topics will focus on
three main themes:
1. Cost
2. Competition
3. Innovation
• Purpose: To identify challenges, highlight trends
and explore innovative approaches
Presenters:
Keynote speakers and Panelists are being chosen
for their expertise and dynamic perspectives on
themes and related topics. They will include:
1. National health care leaders from
industry, government, academia and public
policy groups.
2. Experts in the health care field.
•
Planning:
Meetings are underway to solicit input on topics. Invited to participate are:
•
•
•
•
•
•
•
•
•
•
Healthcare industry trade associations (e.g., AHIP, AHA, AMA, PhARMA)
Health insurance companies
Pharmaceutical companies
Hospitals
Physicians
Research and policy institutes (e.g., U.S. Chamber of Commerce,
Bipartisan Policy Center, The Heritage Foundation, Brookings Institution,
Robert Wood Johnson Foundation)
Private attorneys representing healthcare industry clients
Academic experts in healthcare policy, law, economics
Consumer advocates
Government officials (States, DOJ, FTC)
First Up: Fall Meeting, Nov. 28-30
Two panels of particular interest to AGs:
• 1. Health Care Consolidation: Antitrust
Review and Enforcement Update
• 2. Pharmaceuticals: Issues Affecting Cost and
Competition
Fall Meeting, Nov. 28-30
Panel 1:
Health Care Consolidation:
Antitrust Review and Enforcement Update
1. Insurance market concentration: Lessons learned
from recent state and federal reviews of proposed
insurance company mergers.
2. Hospitals & horizontal integration: The role of
antitrust regulators as illustrated by recent cases.
3. Physician practices & vertical integration:
Recent antitrust reviews and new approaches.
Fall Meeting, Nov. 28-30
Panel 2: Pharmaceuticals:
Issues Affecting Cost and Competition
1. Consolidation of pharmaceutical companies –brand
and generic
2. Pay for delay in manufacture of generic drugs
3. REMS (Risk Evaluation and Mitigation Strategies) as
barrier to generic drug market entry
Topics Under Consideration
for upcoming meetings
• Policy innovation at the
state-level
• Drivers and impacts of
industry consolidation
• Innovative approaches
to control costs
• Prescription drug
pricing
• Fee-for-service vs.
value-based provider
payment models
• Healthcare data
transparency
• Future reform
approaches
Plan Ahead:
Winter Meeting: Washington, DC
Feb. 27-March 1, 2017;
Summit Meeting: New York City
April 26-28, 2017;
Summer Meeting: TBD
June 20-22, 2017
Conclusion:
Attorney General Jepsen welcomes your
comments and suggestions:
Potential panelists and keynote speakers;
Topics of particular interest or concern;
Questions and/or Comments?
Thank You
Deputy Attorney General
Perry Zinn Rowthorn
Contact me: [email protected]